[1]
|
A. Espi, J. Arenas, E. Garcia-Granero, E. Marti and S. Lledo, “Relationship of Curative Surgery on Natural Killer Cell Activity in Colorectal Cancer,” Diseases of the Colon & Rectum, Vol. 39, No. 4, 1996, pp. 429-434. doi:10.1007/BF02054059
|
[2]
|
B. Welden, G. Gates, R. Mallari and N. Garrett, “Effects of Anesthetics and Analgesics on Natural Killer Cell Activity,” AANA Journal, Vol. 77, No. 4, 2009, pp. 287-292.
|
[3]
|
N. Ohtani, Y. Yasui, D. Watanabe, M. Kitamura, K. Shoji and E. Masaki, “Perioperative Infusion of Dexmedetomidine at a High Dose Reduces Postoperative Analgesic Requirements: A Randomized Control Trial,” Journal of Anesthesia, Vol. 25, No. 6, 2011, pp. 872-878. doi:10.1007/s00540-011-1239-8
|
[4]
|
K. Yuki, S. G. Soriano and M. Shimaoka, “Sedative Drug Modulates T-Cell and Lymphocyte Function-Associated Antigen-1 Function,” Anesthesia & Analgesia, Vol. 112, No. 4, 2011, pp. 830-838. doi:10.1213/ANE.0b013e31820dcabb
|
[5]
|
D. M. Parkin, F. Bray, J. Ferlay and P. Pisani, “Global Cancer Statistics,” CA: A Cancer Journal for Clinicians, Vol. 55, No. 2, 2005, pp. 74-108. doi:10.3322/canjclin.55.2.74
|
[6]
|
A. M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius and B. Grubeck-Loebenstein, “Increase of Regulatory T Cells in the Peripheral Blood of Cancer Patients,” Clinical Cancer Research, Vol. 9, No. 2, 2003, pp. 606-612.
|
[7]
|
E. Barbera-Guillem, M. B. Nelson, B. Barr, et al., “Lymphocyte Pathology in Human Colorectal Cancer. Experimental and Clinical Therapeutic Effects of Partial B Cell Depletion,” Cancer Immunology, Immunotherapy, Vol. 48, No. 10, 2000, pp. 541-549. doi:10.1007/PL00006672
|
[8]
|
L. Pilla, P. Squarcina, J. Coppa, et al., “Natural Killer and NK-Like T-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein,” Cancer Research, Vol. 65, No. 9, 2005, pp. 3942-3949. doi:10.1158/0008-5472.CAN-04-3493
|
[9]
|
I. Rozet, “Anesthesia for Functional Neurosurgery: The Role of Dexmedetomidine,” Current Opinion in Anaesthesiology, Vol. 21, No. 5, 2008, pp. 537-543. doi:10.1097/ACO.0b013e32830edafd
|
[10]
|
Z. L. Wu, Z. F. Zhou, L. X. Xu and S. Z. She, “Effect of Dexmedetomidine on Patient-Controlled Intravenous Analgesia with Fentanyl in Elderly Patients after Total Hip Replacement,” Nan Fang Yi Ke Da Xue Xue Bao, Vol. 31, No. 4, 2011, pp. 701-704.
|
[11]
|
T. Taniguchi, Y. Kidani, H. Kanakura, Y. Takemoto and K. Yamamoto, “Effects of Dexmedetomidine on Mortality Rate and Inflammatory Responses to Endotoxin-Induced Shock in Rats,” Critical Care Medicine, Vol. 32, No. 6, 2004, pp. 1322-1326. doi:10.1097/01.CCM.0000128579.84228.2A
|